InvestSMART

Chimeric Therapeutics Limited (ASX: CHM) - Announcements

Current share price for CHM : $0.019 0.001 (5.56%)+

ASX company news and announcements for Chimeric Therapeutics Limited (CHM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Chimeric Therapeutics Limited (CHM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Chimeric Therapeutics Limited (CHM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Chimeric Therapeutics Limited (CHM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$1 Notice under section 708A 10 Dec 2024 5:55PM $0.007 $0.019 risen by 171.43%
$1 Application for quotation of securities - CHM 10 Dec 2024 5:51PM $0.007 $0.019 risen by 171.43%
$1 Notification regarding unquoted securities - CHM 10 Dec 2024 5:45PM $0.007 $0.019 risen by 171.43%
$1 Notice under section 708A 9 Dec 2024 5:38PM $0.008 $0.019 risen by 137.50%
$1 Application for quotation of securities - CHM 9 Dec 2024 5:31PM $0.008 $0.019 risen by 137.50%
$1 Results of Meeting 4 Dec 2024 12:24PM $0.010 $0.019 risen by 90%
$1 Presentation to Extraordinary General Meeting 4 Dec 2024 10:40AM $0.010 $0.019 risen by 90%
$1 Chimeric receives $4.17m R&D tax incentive 28 Nov 2024 9:38AM $0.009 $0.019 risen by 111.11%
$1 Constitution 14 Nov 2024 6:19PM $0.010 $0.019 risen by 90%
$1 Results of Meeting 12 Nov 2024 12:36PM $0.010 $0.019 risen by 90%
$1 AGM Presentation and CEO Appointment 12 Nov 2024 9:56AM $0.010 $0.019 risen by 90%
$1 Notice under section 708A 5 Nov 2024 4:24PM $0.012 $0.019 risen by 58.33%
$1 Application for quotation of securities - CHM 5 Nov 2024 4:20PM $0.012 $0.019 risen by 58.33%
$1 Notice of Extraordinary General Meeting December 2024 5 Nov 2024 8:32AM $0.010 $0.019 risen by 90%
$1 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2024 2:47PM $0.009 $0.019 risen by 111.11%
$1 Investor webinar 24 Oct 2024 4:11PM $0.009 $0.019 risen by 111.11%
$1 Dose finding complete in ADVENT-AML Phase 1b clinical trial 24 Oct 2024 9:55AM $0.009 $0.019 risen by 111.11%
$1 Application for quotation of securities - CHM 24 Oct 2024 9:54AM $0.009 $0.019 risen by 111.11%
$1 Prospectus 23 Oct 2024 8:57AM $0.009 $0.019 risen by 111.11%
$1 Reinstatement to Official Quotation 21 Oct 2024 7:01PM $0.014 $0.019 risen by 35.71%
$1 ESG Report 21 Oct 2024 3:12PM $0.014 $0.019 risen by 35.71%
$1 Corporate Governance Statement and Appendix 4G 21 Oct 2024 3:12PM $0.014 $0.019 risen by 35.71%
$1 Annual Report 2024 21 Oct 2024 3:10PM $0.014 $0.019 risen by 35.71%
$1 Proposed issue of securities - CHM 21 Oct 2024 11:49AM $0.014 $0.019 risen by 35.71%
$1 Proposed issue of securities - CHM 21 Oct 2024 11:49AM $0.014 $0.019 risen by 35.71%

176 - 200 of 643 results

Page 8 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.